These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 13145776)

  • 1. [Effectiveness of therapy inducing contraction of spleen in a rare case of visceral leishmaniasis in adult].
    MAJANI A
    Rass Clin Ter; 1953; 52(4):241-6. PubMed ID: 13145776
    [No Abstract]   [Full Text] [Related]  

  • 2. [N-methylglucamine antimoniate (glucantime) in therapy of infantile visceral leishmaniasis; a further case of autocthonous infantile visceral leishmaniasis on the island of Elba].
    CAMBI P
    Minerva Dermatol; 1955 Apr; 30(4):126-8. PubMed ID: 14383431
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative evaluation of effectiveness of antimony preparations in the treatment of visceral leishmaniasis].
    MIRZOIAN NA
    Med Parazitol (Mosk); 1954; 23(2):161-4. PubMed ID: 13175906
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of antimony dextran glycoside (RL-712) against visceral leishmaniasis in the hamster.
    Mikhail JW; Khayyal MT; Girgis NI
    Bull World Health Organ; 1969; 40(2):327-8. PubMed ID: 5306550
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antimony resistance in the treatment of visceral leishmaniasis].
    MIRZOIAN NA
    Med Parazitol (Mosk); 1957; 26(3):277-80. PubMed ID: 13482777
    [No Abstract]   [Full Text] [Related]  

  • 6. Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis.
    Murray HW
    Acta Trop; 2005 Mar; 93(3):295-301. PubMed ID: 15716043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secretion of antimony and stilbamidine in the treatment of visceral leishmaniasis in children].
    MIKHAILOV VG
    Farmakol Toksikol; 1959; 22(2):175-8. PubMed ID: 13653152
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy.
    Ojha RP; Cervantes D; Fischbach LA
    Clin Infect Dis; 2007 Oct; 45(8):1104; author reply 1005-6. PubMed ID: 17879933
    [No Abstract]   [Full Text] [Related]  

  • 9. Visceral leishmaniasis (kala-azar) and pregnancy.
    Figueiró-Filho EA; Duarte G; El-Beitune P; Quintana SM; Maia TL
    Infect Dis Obstet Gynecol; 2004; 12(1):31-40. PubMed ID: 15460194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of visceral leishmaniasis with n-methyl-glucamine antimoniate].
    BOIX BARRIOS J; SANCHO PASQUAU V
    Presse Med (1893); 1951 Nov; 59(71):1475-7. PubMed ID: 14891720
    [No Abstract]   [Full Text] [Related]  

  • 11. [Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives].
    WILDE H; DI CARLO FC; PESSAT OA
    Rev Med Cordoba; 1956 Sep; 44():319-31. PubMed ID: 13420979
    [No Abstract]   [Full Text] [Related]  

  • 12. Visceral leishmaniasis therapy.
    Cascio G; Titone L
    J Chemother; 1989 Jul; 1(4 Suppl):956-9. PubMed ID: 16312721
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of visceral leishmaniasis with solusurmin in children].
    KARAKHODZHAEV BKh
    Pediatriia; 1953; 4():60-1. PubMed ID: 13088230
    [No Abstract]   [Full Text] [Related]  

  • 14. [Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives: personal observation].
    DI CARLO FC; PESSAT OA; WILDE H
    Dia Med; 1956 Nov; 28(84):2629-31; passim. PubMed ID: 13397380
    [No Abstract]   [Full Text] [Related]  

  • 15. [Azotemic nephritis during antimony therapy of a case of infantile visceral leishmaniasis].
    CHARLAS R; BENABADJI A
    Maroc Med; 1962 Dec; 41():1180-2. PubMed ID: 14020224
    [No Abstract]   [Full Text] [Related]  

  • 16. [Note on the use of drugs with antimony base; a case of kala-azar treated with glucantime].
    GIRAUD P; BERNARD R; VINCENT P
    Arch Fr Pediatr; 1954; 11(6):659-62. PubMed ID: 13198287
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pluri-focal cutaneous leishmaniasis treated with intralesional glucantime].
    Duperrat B; Puissant A; Fischer R; Badillet G; Mascaro JM
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(2):219-20. PubMed ID: 5914173
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous leishmaniasis with boggy induration and simultaneous mucosal disease.
    Mings S; Beck JC; Davidson C; Ondo AL; Shanler SD; Berman J
    Am J Trop Med Hyg; 2009 Jan; 80(1):3-5. PubMed ID: 19141829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of visceral leishmaniasis.
    Ozsoylu S
    Pediatr Hematol Oncol; 2006; 23(5):449-51; author reply 455-7. PubMed ID: 16728366
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cryotherapy with or without intralesional antimony in the treatment of cutaneous leishmaniasis].
    Chaabane H; Masmoudi A; Dammak A; Kchaou W; Akrout F; Zribi M; Boudaya S; Turki H
    Ann Dermatol Venereol; 2009 Mar; 136(3):278-9. PubMed ID: 19328314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.